Prelude Therapeutics Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmington, DE
SEC filing record 1 source field available
Fiscal year end
31 December
Prelude Therapeutics Inc has filed 386 SEC EDGAR filings since 11 Jul 2016

SEC filing history

Showing 26-50 of 386 matching filings.

Per page
25
Current page
2
3

3 filing

Filing date
15 Apr 2026
Reporting date
15 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Mar 2026
Reporting date
05 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-279829

424B5

Filing date
12 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91717

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Feb 2026
Reporting date
04 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Feb 2026
Reporting date
04 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Feb 2026
Reporting date
04 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Feb 2026
Reporting date
04 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-292048

EFFECT filing

Filing date
16 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-292048

S-3 filing

Filing date
10 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91717

SCHEDULE 13G filing

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Oct 2025
Reporting date
17 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
20 Oct 2025
Reporting date
17 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .